Identification of Small Molecule Compounds for Pharmacological Chaperone Therapy of Aspartylglucosaminuria

Aspartylglucosaminuria (AGU) is a lysosomal storage disorder that is caused by genetic deficiency of the enzyme aspartylglucosaminidase (AGA) which is involved in glycoprotein degradation. AGU is a progressive disorder that results in severe mental retardation in early adulthood. No curative therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Banning, Antje, Gülec, Christina, Rouvinen, Juha, Gray, Steven J., Tikkanen, Ritva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120323/
https://www.ncbi.nlm.nih.gov/pubmed/27876883
http://dx.doi.org/10.1038/srep37583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120323/
https://www.ncbi.nlm.nih.gov/pubmed/27876883
http://dx.doi.org/10.1038/srep37583

Ejemplares similares